or Try an Advanced Search...

    Technical Analysis for EPIX - ESSA Pharma Inc.

    Grade Last Price % Change Price Change
    D 6.75 1.50% 0.10
    EPIX closed up 1.5 percent on Friday, May 31, 2024, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical EPIX trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Stochastic Reached Overbought Strength 0.00%
    Weak + Overbought Other 0.00%
    Inside Day Range Contraction 0.00%
    Weak, Overbought and Reversal Signs Reversal 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Crossed Above 20 DMA Bullish 1.50%
    Older End-of-Day Signals for EPIX ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    Possible Inside Day 1 day ago
    Down 1% 1 day ago
    Up 1% 1 day ago
    Rose Above 20 DMA 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    EPIX Chart by TradingView
    Basic chart:

    Profile

    ESSA Pharma Inc. is a pharmaceutical company. The company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA Pharma Inc. is based in Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Cancer Pharmaceutical Treatment Of Cancer Prostate Cancer Histopathology Advanced Prostate Cancer Pharma

    Is EPIX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 21 Insider Stock Buying Reaches US$709.0k On ESSA Pharma
    May 14 ESSA Pharma GAAP EPS of -$0.20 misses by $0.01
    May 14 ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
    Apr 9 ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
    Apr 8 ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
    Mar 8 ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
    Feb 26 12 $10 Stocks That Will Triple
    Feb 16 EPIX: Risk Profile of Patients in Phase 1/2 Trial of Masofaniten Reveals Majority at High Risk for Early Enzalutamide Failure…
    Feb 14 ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results
    Feb 13 ESSA Pharma GAAP EPS of -$0.14
    See more EPIX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.67
    52 Week Low 2.58
    Average Volume 59,916
    200-Day Moving Average 6.18
    50-Day Moving Average 7.08
    20-Day Moving Average 6.37
    10-Day Moving Average 6.31
    Average True Range 0.51
    RSI (14) 54.13
    ADX 20.07
    +DI 16.82
    -DI 17.79
    Chandelier Exit (Long, 3 ATRs) 5.81
    Chandelier Exit (Short, 3 ATRs) 7.04
    Upper Bollinger Bands 7.02
    Lower Bollinger Band 5.71
    Percent B (%b) 0.79
    BandWidth 20.54
    MACD Line -0.13
    MACD Signal Line -0.25
    MACD Histogram 0.1175
    Fundamentals Value
    Market Cap 298.1 Million
    Num Shares 44.2 Million
    EPS -0.60
    Price-to-Earnings (P/E) Ratio -11.25
    Price-to-Sales 0.00
    Price-to-Book 3.09
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.13
    Resistance 3 (R3) 7.09 6.94 7.06
    Resistance 2 (R2) 6.94 6.84 6.95 7.04
    Resistance 1 (R1) 6.84 6.78 6.88 6.88 7.02
    Pivot Point 6.69 6.69 6.70 6.70 6.69
    Support 1 (S1) 6.59 6.59 6.63 6.63 6.48
    Support 2 (S2) 6.44 6.53 6.45 6.46
    Support 3 (S3) 6.34 6.44 6.44
    Support 4 (S4) 6.38